224 related articles for article (PubMed ID: 20442861)
1. Keratinocytes determine Th1 immunity during early experimental leishmaniasis.
Ehrchen JM; Roebrock K; Foell D; Nippe N; von Stebut E; Weiss JM; Münck NA; Viemann D; Varga G; Müller-Tidow C; Schuberth HJ; Roth J; Sunderkötter C
PLoS Pathog; 2010 Apr; 6(4):e1000871. PubMed ID: 20442861
[TBL] [Abstract][Full Text] [Related]
2. Epidermal expression of I-TAC (Cxcl11) instructs adaptive Th2-type immunity.
Roebrock K; Sunderkötter C; Münck NA; Wolf M; Nippe N; Barczyk K; Varga G; Vogl T; Roth J; Ehrchen J
FASEB J; 2014 Apr; 28(4):1724-34. PubMed ID: 24398292
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
Mocci S; Coffman RL
J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice.
Von Stebut E; Ehrchen JM; Belkaid Y; Kostka SL; Molle K; Knop J; Sunderkotter C; Udey MC
J Exp Med; 2003 Jul; 198(2):191-9. PubMed ID: 12860932
[TBL] [Abstract][Full Text] [Related]
5. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
Mocci S; Coffman RL
J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
[TBL] [Abstract][Full Text] [Related]
6. Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major.
Yamakami K; Akao S; Tadakuma T; Nitta Y; Miyazaki J; Yoshizawa N
Immunology; 2002 Apr; 105(4):515-23. PubMed ID: 11985672
[TBL] [Abstract][Full Text] [Related]
7. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
8. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
[TBL] [Abstract][Full Text] [Related]
9. In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis.
Li J; Scott P; Farrell JP
Infect Immun; 1996 Dec; 64(12):5248-54. PubMed ID: 8945573
[TBL] [Abstract][Full Text] [Related]
10. IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance.
Lazarski CA; Ford J; Katzman SD; Rosenberg AF; Fowell DJ
PLoS One; 2013; 8(8):e71949. PubMed ID: 23991011
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis.
Govender M; Hurdayal R; Martinez-Salazar B; Gqada K; Pillay S; Gcanga L; Passelli K; Nieuwenhuizen NE; Tacchini-Cottier F; Guler R; Brombacher F
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275010
[TBL] [Abstract][Full Text] [Related]
12. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
14. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
[TBL] [Abstract][Full Text] [Related]
15. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
[TBL] [Abstract][Full Text] [Related]
16. The role of IL-12 in regulation of T helper cell subsets in vivo. Lessons from experimental cutaneous leishmaniasis.
Scott P; Hondowicz B; Eaton A; Scharton-Kersten T
Ann N Y Acad Sci; 1996 Oct; 795():250-6. PubMed ID: 8958936
[No Abstract] [Full Text] [Related]
17. JNK1 is required for T cell-mediated immunity against Leishmania major infection.
Constant SL; Dong C; Yang DD; Wysk M; Davis RJ; Flavell RA
J Immunol; 2000 Sep; 165(5):2671-6. PubMed ID: 10946297
[TBL] [Abstract][Full Text] [Related]
18. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
[TBL] [Abstract][Full Text] [Related]
20. Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy.
Heinzel FP; Rerko RM
J Exp Med; 1999 Jun; 189(12):1895-906. PubMed ID: 10377185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
